Kalaris Therapeutics, Inc. KLRS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-30
Kalaris Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 66,151 | $381,691 |
| MILLENNIUM MANAGEMENT LLC | 59,534 | $343,511 |
| TWO SIGMA INVESTMENTS, LP | 30,650 | $176,850 |
Source: SEC EDGAR filings · CIK 0001754068 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.